Smith & Nephew (SNN) Stock Rating Upgraded by UBS

Smith & Nephew (NYSE:SNN) was upgraded by research analysts at UBS from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports.

SNN has been the subject of several other reports. Canaccord Genuity reissued a “buy” rating and issued a $45.00 price objective on shares of Smith & Nephew in a research report on Friday, January 5th. Zacks Investment Research cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Tuesday, April 3rd. ValuEngine cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, February 9th. HSBC raised shares of Smith & Nephew from a “hold” rating to a “buy” rating in a research report on Monday, March 26th. Finally, JPMorgan Chase raised shares of Smith & Nephew from a “neutral” rating to an “overweight” rating in a research report on Thursday, January 25th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $43.50.

How to Become a New Pot Stock Millionaire

Smith & Nephew stock opened at $38.41 on Wednesday. The stock has a market capitalization of $16,781.43, a price-to-earnings ratio of 20.22, a P/E/G ratio of 2.22 and a beta of 0.62. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.03 and a quick ratio of 1.06. Smith & Nephew has a 1 year low of $31.80 and a 1 year high of $40.43.

A number of institutional investors have recently added to or reduced their stakes in SNN. Cambiar Investors LLC lifted its position in shares of Smith & Nephew by 10.0% in the 4th quarter. Cambiar Investors LLC now owns 5,935,389 shares of the medical equipment provider’s stock worth $207,798,000 after purchasing an additional 537,369 shares during the period. Nuance Investments LLC lifted its position in shares of Smith & Nephew by 31.0% in the 4th quarter. Nuance Investments LLC now owns 2,043,781 shares of the medical equipment provider’s stock worth $71,553,000 after purchasing an additional 484,016 shares during the period. Renaissance Technologies LLC lifted its position in shares of Smith & Nephew by 867.5% in the 4th quarter. Renaissance Technologies LLC now owns 333,800 shares of the medical equipment provider’s stock worth $11,686,000 after purchasing an additional 299,300 shares during the period. Millennium Management LLC lifted its position in shares of Smith & Nephew by 24.0% in the 4th quarter. Millennium Management LLC now owns 1,350,040 shares of the medical equipment provider’s stock worth $47,265,000 after purchasing an additional 261,072 shares during the period. Finally, Bank of Montreal Can lifted its position in shares of Smith & Nephew by 1,088.9% in the 4th quarter. Bank of Montreal Can now owns 281,224 shares of the medical equipment provider’s stock worth $9,846,000 after purchasing an additional 257,569 shares during the period. 6.89% of the stock is owned by institutional investors.

WARNING: This article was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/04/20/smith-nephew-snn-stock-rating-upgraded-by-ubs.html.

Smith & Nephew Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

The Fly

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply